Life Science Cares Philadelphia has welcomed Arun Kejariwal to its Board of Advisors, the organization announced on November 11, 2026. Kejariwal brings more than 25 years of leadership experience in the Greater Philadelphia life sciences community. He currently serves as Chief Operating Officer of LifeRaft Biosciences and is the founder of Arke Solutions.
Life Science Cares Philadelphia noted that Kejariwal is already familiar with its mission. Earlier this year, he was one of six climbers who summited Mount Kilimanjaro to raise funds and awareness for the organization. The organization said it’s grateful for his commitment and excited to have his experience, leadership and passion helping it disrupt poverty across Greater Philadelphia.
Kejariwal said the region’s life sciences community has given him so much, and that “Life Science Cares helps level the playing field for our neighbors and students.” He added that he’s grateful to be part of it.
About Arun Kejariwal
Kejariwal joined LifeRaft Biosciences as Chief Operating Officer in October 2026. He leads operations, development planning and partnerships for the company’s investigational membrane-stabilizing therapy, Vepoloxamer, which is being developed for radiation-induced severe oral mucositis in head and neck cancer patients. Through Arke Solutions, which he founded in 2025, he advises founders, executive teams and investors building early-stage therapeutics and platform companies. He also serves as a board advisor to Catailyst and on the board of directors of Superior Credit Union.
Before that, Kejariwal spent five years at Spark Therapeutics, most recently as Chief of Staff to the CEO and Corporate Management Team. He previously served as Asset General Manager for Huntington’s disease and Product Strategy Lead for CNS and ocular programs. Earlier, he was Senior Director and Head of Portfolio Capability Development and Innovation at GSK. He spent more than eight years at Pfizer in portfolio, decision analysis and commercial analytics leadership roles, where he helped develop the company’s gene therapy strategy.
Kejariwal began his industry career with 10 years at Merck, starting as a Research Chemical Engineer in the Biologics Pilot Plant, where he led Merck’s first GMP monoclonal antibody project. He then moved into R&D strategy and portfolio analytics. Before Merck, he held engineering and GMP compliance roles, including at Siegfried.
Kejariwal holds an MBA from Saint Joseph’s University’s Haub School of Business, an M.S. in Chemical Engineering from Widener University, and a B.E. in Chemical Engineering from Manipal Academy of Higher Education.
About Life Science Cares Philadelphia
Life Science Cares Philadelphia is a collective effort of the life sciences industry to reduce the impact of poverty on neighbors in the greater Philadelphia area. By uniting the human and financial resources of life science companies and industry leaders, it supports the service organizations doing the most effective anti-poverty work in the region. Its programs include Project Onramp, which offers paid life science internships to low-income, first-generation college students. Life Science Cares started in Boston and expanded to Philadelphia in 2019.
